Drug Discovery for Leishmaniasis (Hardcover)

Idioma: inglés

Editorial: Royal Society of Chemistry, Cambridge, 2017

1782628894 / 9781782628897

Librería: Grand Eagle Retail, Bensenville, IL, Estados Unidos de AmericaGrand Eagle Retail

Vendedor de 5 estrellas

Vendedor de IberLibro desde 12 de octubre de 2005

Tapa dura

Condición: Nuevo

EUR 229,39

 Gastos de envío gratis 
Se envía dentro de Estados Unidos de America

Cantidad disponible: 1 disponible

Añadir al carrito
Devoluciones gratuitas de 30 días

Descripción del artículo del vendedor

Hardcover. For human health, leishmaniasis is among the most important protozoan diseases, superseded only by malaria. Globally, 10 to 12 million people are infected with 1.5 million new cases every year. The development of cheaper new drugs is urgently needed for this neglected disease that is developing resistance to current treatments. Chemotherapy remains the only treatment option for the bulk of patients. However, this is largely unaffordable for most. In the past three years numerous advances in drug discovery have been made for treating this disease by exploiting diverging metabolic pathways between the Leishmania enzymes and their hosts, using nanotechnology to target the immune cell phagolysosomes where Leishmania resides.Drug Discovery for Leishmaniasis aims to provide a perspective of the current treatments and their challenges, blended with the emerging strategies and methodologies that will drive new target appraisals and drug developments, as well as addressing the molecular basis of resistance in Leishmania.Recent studies have shown that leishmaniasis affects some of the poorest people in the world, with 95% of fatal cases occurring in only 6 countries. With the WHO goal of eliminating this public health problem in the South-east Asia Region by 2020, this book will be important for anyone who is interested in neglected tropical diseases. Drug Discovery for Leishmaniasis aims to provide a perspective of the current treatments and their challenges, blended with the emerging strategies and methodologies that will drive new target appraisals and drug developments, as well as addressing the molecular basis of resistance in Leishmania. Shipping may be from multiple locations in the US or from the UK, depending on stock availability.…

N° de ref. del artículo 9781782628897

Título
Drug Discovery for Leishmaniasis (Hardcover)
Autor
Luis Rivas
Editorial
Royal Society of Chemistry, Cambridge
Año de publicación
2017
Estado
new
Encuadernación
Hardcover
Idioma
inglés
ISBN 10
1782628894
ISBN 13
9781782628897

Grand Eagle Retail

Bensenville, IL, Estados Unidos de America

Vendedor de 5 estrellas

Vendedor de IberLibro desde 12 de octubre de 2005

Tarifas de envío en Estados Unidos de America

ArtículoDe 6 a 14 días hábilesDe 6 a 16 días hábiles
Primer artículoEUR 0,00EUR 0,00
Los plazos de entrega los establecen los vendedores y varían según el transportista y la ubicación. Los pedidos que pasan por la aduana pueden sufrir retrasos y los compradores son responsables de los aranceles o tarifas asociadas. Los vendedores pueden ponerse en contacto con usted en relación con cargos adicionales para cubrir cualquier aumento en los costes de envío de los artículos.

Métodos de pago

  • Visa
  • Mastercard
  • American Express
  • Carte Bleue
  • Apple Pay
  • Google Pay

Información empresarial del vendedor

APOLLO ONLINE CORP.

605 Geddes Street
Wilmington, DE Estados Unidos de America 19805